BioRestorative Therapies, Inc. (BRTX) stock
BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
$1.49−0.01 (-0.67%)
Close on Nov 13, 2026Market cap $37.96MP/E –Yield –
BioRestorative Therapies operating margin
Operating margin is operating income as a percentage of revenue.
BioRestorative Therapies's operating margin for the twelve months ending Mar 31, 2026 was -3975.0%. For fiscal 2025 it was -4350.1%, against -2881.6% the year before. The highest annual figure on record is -1140.1% in fiscal 2015.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -4350.1% | −1468.5 |
| FY2024 | Dec 31, 2024 | -2881.6% | +7557.9 |
| FY2023 | Dec 31, 2023 | -10439.5% | +5398.6 |
| FY2022 | Dec 31, 2022 | -15838.1% | +41352.9 |
| FY2021 | Dec 31, 2021 | -57191.0% | −53616.9 |
| FY2020 | Dec 31, 2020 | -3574.1% | +2912.0 |
| FY2019 | Dec 31, 2019 | -6486.2% | +403.6 |
| FY2018 | Dec 31, 2018 | -6889.8% | +3448.8 |
| FY2017 | Dec 31, 2017 | -10338.6% | +11075.4 |
| FY2016 | Dec 31, 2016 | -21414.0% | −20273.9 |
| FY2015 | Dec 31, 2015 | -1140.1% | +43.2 |
| FY2014 | Dec 31, 2014 | -1183.3% | +281689.9 |
| FY2013 | Dec 31, 2013 | -282873.2% | −247127.2 |
| FY2012 | Dec 31, 2012 | -35746.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -14612.6% | +4617.6 |
| Q4 FY2025 | Dec 31, 2025 | -19516.8% | −13304.0 |
| Q3 FY2025 | Sep 30, 2025 | -31432.3% | −30453.3 |
| Q2 FY2025 | Jun 30, 2025 | -1089.8% | +1681.1 |
| Q1 FY2025 | Mar 31, 2025 | -19230.1% | −7489.4 |
| Q4 FY2024 | Dec 31, 2024 | -6212.8% | +10474.7 |
| Q3 FY2024 | Sep 30, 2024 | -979.0% | +9133.2 |
| Q2 FY2024 | Jun 30, 2024 | -2770.8% | +2061.0 |
| Q1 FY2024 | Mar 31, 2024 | -11740.7% | +6722.9 |
| Q4 FY2023 | Dec 31, 2023 | -16687.5% | +109850.5 |
| Q3 FY2023 | Sep 30, 2023 | -10112.2% | +5783.3 |
| Q2 FY2023 | Jun 30, 2023 | -4831.9% | +1678.2 |
| Q1 FY2023 | Mar 31, 2023 | -18463.6% | +13122.6 |
| Q4 FY2022 | Dec 31, 2022 | -126537.9% | −46352.6 |
| Q3 FY2022 | Sep 30, 2022 | -15895.5% | +30213.1 |
| Q2 FY2022 | Jun 30, 2022 | -6510.0% | +17191.7 |
| Q1 FY2022 | Mar 31, 2022 | -31586.2% | +52050.8 |
| Q4 FY2021 | Dec 31, 2021 | -80185.3% | −75159.1 |
| Q3 FY2021 | Sep 30, 2021 | -46108.6% | −42040.2 |
| Q2 FY2021 | Jun 30, 2021 | -23701.8% | −21272.3 |
| Q1 FY2021 | Mar 31, 2021 | -83637.0% | −80487.0 |
| Q4 FY2020 | Dec 31, 2020 | -5026.3% | +1710.8 |
| Q3 FY2020 | Sep 30, 2020 | -4068.4% | +718.4 |
| Q2 FY2020 | Jun 30, 2020 | -2429.4% | +4437.7 |
| Q1 FY2020 | Mar 31, 2020 | -3150.0% | +4878.8 |
| Q4 FY2019 | Dec 31, 2019 | -6737.1% | +772.9 |
| Q3 FY2019 | Sep 30, 2019 | -4786.8% | −215.0 |
| Q2 FY2019 | Jun 30, 2019 | -6867.1% | −1325.7 |
| Q1 FY2019 | Mar 31, 2019 | -8028.7% | +3712.0 |
| Q4 FY2018 | Dec 31, 2018 | -7510.0% | −3372.5 |
| Q3 FY2018 | Sep 30, 2018 | -4571.8% | +6325.9 |
| Q2 FY2018 | Jun 30, 2018 | -5541.4% | +7303.6 |
| Q1 FY2018 | Mar 31, 2018 | -11740.7% | +23821.7 |
| Q4 FY2017 | Dec 31, 2017 | -4137.5% | +26472.9 |
| Q3 FY2017 | Sep 30, 2017 | -10897.7% | +23406.5 |
| Q2 FY2017 | Jun 30, 2017 | -12845.1% | +421.1 |
| Q1 FY2017 | Mar 31, 2017 | -35562.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -30610.4% | – |
| Q3 FY2016 | Sep 30, 2016 | -34304.2% | – |
| Q2 FY2016 | Jun 30, 2016 | -13266.1% | – |
See a number that looks wrong?